For nearly 60% of Americans, pharmacies are the first stop for non-emergency care—providing vaccinations, medication management, chronic disease screening, and public health support. When a community pharmacy closes, medication adherence drops, particularly for cardiovascular drugs, driving higher downstream costs across the system.

The rise of “pharmacy deserts” is becoming a serious healthcare problem as community pharmacies are being squeezed out of local markets.

Michael Abrams discusses the forces driving an increasingly unsustainable traditional community pharmacy model, and what it means for care access and cost in his article for Pharmaceutical Commerce.

Read his full feature piece here.